News of Note—Anthem will cover artificial pancreas; Takeda posts update on depression-monitoring smartwatch study

newspaper

> Anthem, the second-largest insurance company nationwide, will cover artificial pancreas systems. Drug Delivery Business News story

> Takeda and Cognition Kit reported strong compliance in 30-person trial investigating the use of the Apple Watch to monitor people with major depressive disorder. Release | Read more from FierceMedTech

> The FDA cleared Kaléo’s AUVI-Q 0.1 mg Auto-injector, the first and only epinephrine autoinjector designed to treat allergic reactions in infants and small children. Release